RadNet Inc. (RDNT) at a glance
RadNet Inc. (RDNT) is a mid-cap Healthcare company. It trades at $75.49, with a P/E of 1425.8, a -0.7% profit margin and revenue growth of 22.1%. It does not pay a dividend. Vestovix scores it 44/100 overall. Its strongest dimension is Growth (78/100) and its weakest is Value (10/100). It carries above-market volatility, so expect larger swings.
- Price
- $75.49
- Market cap
- $4.46B
- P/E ratio
- 1425.8
- Dividend yield
- None
- Beta
- 1.39
- 52-week range
- $50.82 to $85.84
Value
10
Growth
78
Income
40
Safety
38
Momentum
65
Other Healthcare stocks
See allDHR.PR.A50
Danaher Corp
$1,841.01+0.00%
2.58% yield
LLY68
Eli Lilly and Company
$1,116.20-0.96%
0.57% yield
JNJ61
Johnson & Johnson
$266.20+0.73%
2.18% yield
ABBV46
AbbVie Inc.
$257.12-0.86%
2.96% yield
UNH56
UnitedHealth Group Incorporated
$378.73-0.34%
2.16% yield
MRK60
Merck & Co., Inc.
$144.01-0.98%
2.79% yield
ABT54
Abbott Laboratories
$103.57+0.92%
2.16% yield
AMGN65
Amgen Inc.
$378.21-1.05%
2.76% yield